Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eleven research firms that are presently covering the stock, ...
Johnson & Johnson said on Friday it resumed the limited market release of its Varipulse heart device in the United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback